Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells

Oncogene

Volumn 21, Issue 46, 2002, Pages 7077-7091

  Briggs, Joseph ^a   Chamboredon, Sandrine ^b   Castellazzi, Marc ^b   Kerry, Julie A ^a   Bos, Timothy J ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

C Jun; Osteonectin; SPARC; Target genes

Indexed keywords

GENE PRODUCT; OSTEONECTIN; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CELL MOTILITY; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DROSOPHILA; GENE ACTIVATION; GENE DELETION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTO ONCOGENE; TRANSCRIPTION REGULATION;

BREAST NEOPLASMS; CELL MOVEMENT; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTAGENESIS, SITE-DIRECTED; NEOPLASM INVASIVENESS; OSTEONECTIN; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-JUN; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0037057334     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1205857     Document Type: Article

References (68)

1. Bamberger AM, Methner C, Lisboa BW, Stadtler C, Schulte HM, Loning T and Milde-Langosch K. (1999). Int J. Cancer, 84, 533-538.
2. Basso J, Briggs J, Findlay C and Bos T. (2000). Oncogene, 19, 4876-4885.
3. Bellahcene A and Castronovo V. (1995). Am. J. Pathol., 146, 95-100.
4. Benbrook DM and Jones NC. (1990). Oncogene, 5, 295-302.
5. Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscott SJ, Weintraub H and Verma IM. (1992). Cell, 68, 507-519.
6. Bergers G, Graninger P, Braselmann S, Wrighton C and Busslinger M. (1995). Mol. Cell. Biol., 15, 3748-3758.
7. Bos TJ, Margiotta P, Bush L and Wasilenko W. (1999). Int. J. Cancer, 81, 404-410.
8. Bradshaw AD and Sage EH. (2001). J. Clin. Invest., 107, 1049-1054.
9. Brekken RA and Sage EH. (2001). Matrix Biol., 19, 816-827.
10. Brown TJ, Shaw PA, Karp X, Huynh MH, Begley H and Ringuette MJ. (1999). Gynecol. Oncol., 75, 25-33.
11. Chen BK and Chang WC. (2000). Proc. Natl. Acad. Sci. USA, 97, 10406-10411.
12. Chinenov Y and Kerppola IK. (2001). Oncogene, 20, 2438-2452.
13. Colombo MP, Ferrari G, Biondi G, Galasso D, Howe CC and Parmiani G. (1991). Eur. J. Cancer, 27, 58-62.
14. Courey AJ and Tjian R. (1988). Cell, 55, 887-898.
15. De Cesare D, Vallone D, Caracciolo A, Sassone-Corsi P, Nerlov C and Verde P. (1995). Oncogene, 11, 365-376.
16. Dennig J, Beato M and Suske G. (1996). EMBO J., 15, 5659-5667.
17. Gee JM, Barroso AF, Ellis IO, Robertson JF and Nicholson RI. (2000). Int. J. Cancer, 89, 177-186.
18. Gee JM, Ellis IO, Robertson JF, Willsher P, McClelland RA, Hewitt KN, Blamey RW and Nicholson RI. (1995). Int. J. Cancer, 64, 269-273.
19. Gilles C, Bassuk JA, Pulyaeva H, Sage EH, Foidart JM and Thompson EW. (1998). Cancer Res., 58, 5529-5536.
20. Graham JD, Balleine RL, Milliken JS, Bilous AM and Clarke CL. (1997). Eur. J. Cancer, 33, 1654-1660.
21. Greenwood JA and Murphy-Ullrich JE. (1998). Microsc. Res. Tech., 43, 420-432.
22. Hadman M, Gabos L, Loo M, Sehgal A and Bos TJ. (1996). Oncogene, 12, 135-142.
23. Hadman M, Loo M and Bos TJ. (1993). Oncogene, 8, 1895-1903.
24. Horne GM, Anderson JJ, Tiniakos DG, McIntosh GG, Thomas MD, Angus B, Henry JA, Lennard TW and Horne CH. (1996). Br. J. Cancer, 73, 29-35.
25. Jacob K, Webber M, Benayahu D and Kleinman HK. (1999). Cancer Res., 59, 4453-4457.
26. Jiang Y, Goldberg ID and Shi YE. (2002). Oncogene, 21, 2245-2252.
27. Kardassis D, Papakosta P, Pardali K and Moustakas A. (1999). J. Biol. Chem., 274, 29572-29581.
28. Kato Y, Frankenne F, Noel A, Sakai N, Nagashima Y, Koshika S, Miyazaki K and Foidart JM. (2000). Pathol. Oncol. Res., 6, 24-26.
29. Kim Y, Park, Lee, Ko and Yang. (1998). J. Korean Med. Sci., 13, 652-657.
30. Kobierski LA, Chu HM, Tan Y and Comb MJ. (1991). Proc. Natl. Acad. Sci. USA, 88, 10222-10226.
31. Kraemer M, Tournaire R, Dejong V, Montreau N, Briane D, Derbin C and Binetruy B. (1999). Cell Growth Differ., 10, 193-200.
32. Ledda F, Bravo AI, Adris S, Bover L, Mordoh J and Podhajcer OL. (1997a). J. Invest. Dermatol., 108, 210-214.
33. Ledda MF, Adris S, Bravo Al, Kairiyama C, Bover L, Chernajovsky Y, Mordoh J and Podhajcer OL. (1997b). Nat. Med., 3, 171-176.
34. Majello B, De Luca P and Lania L. (1997). J. Biol. Chem., 272, 4021-4026.
35. Mettouchi A, Cabon F, Montreau N, Vernier P, Mercier G, Blangy D, Tricoire H, Vigier P and Binetruy B. (1994). EMBO J., 13, 5668-5678.
36. Milde-Langosch K, Bamberger AM, Methner C, Rieck G and Loning T. (2000). Int. J. Cancer, 87, 468-472.
37. Mok SC, Chan WY, Wong KK, Muto MG and Berkowitz RS. (1996). Oncogene, 12, 1895-1901.
38. Motamed K. (1999). Int. J. Biochem. Cell Biol., 31, 1363-1366.
39. Nishitani J, Nishinaka T, Cheng CH, Rong W, Yokoyama KK and Chiu R. (1999). J. Biol. Chem., 274, 5454-5461.
40. Porte H, Chastre E, Prevot S, Nordlinger B, Empereur S, Basset P, Chambon P and Gespach C. (1995). Int. J. Cancer, 64, 70-75.
41. Porte H, Triboulet JP, Kotelevets L, Carrat F, Prevot S, Nordlinger B, DiGioia Y, Wurtz A, Comoglio P, Gespach C and Chastre E. (1998). Clin. Cancer Res., 4, 1375-1382.
42. Porter PL, Sage EH, Lane TF, Funk SE and Gown AM. (1995). J. Histochem. Cytochem., 43, 791-800.
43. Reed MJ and Sage EH. (1996). Curr. Top. Microbiol. Immunol., 213, 81-94.
44. Rinehart-Kim J, Johnston M, Birrer M and Bos T. (2000). Int. J. Cancer, 88, 180-190.
45. Rosenblatt S, Bassuk JA, Alpers CE, Sage EH, Timpl R and Preissner KT. (1997). Biochem. J., 324, 311-319.
46. Ryseck RP and Bravo R. (1991). Oncogene, 6, 533-542.
47. Sambrook J, Fritsch EF and Manatis T. (1989). A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press,.
48. Schneider I. (1972). J. Embryol. Exp. Morphol., 27, 353-365.
49. Schüle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM and Evans RM. (1990). Cell, 62, 1217-1226.
50. Shaulian E and Karin M. (2001). Oncogene, 20, 2390-2400.
51. Smith LM, Wise SC, Hendricks DT, Sabichi AL, Bos T, Reddy P, Brown PH and Birrer MJ. (1999). Oncogene, 18, 6063-6070.
52. Stein B, Baldwin JAS, Ballard DW, Greene WC, Angel P and Herrlich P. (1993a). EMBO J., 12, 3879-3891.
53. Stein B, Cogswell PC and Baldwin JAS. (1993b). Mol. Cell. Biol., 13, 3964-3974.
54. Sturm RA, Satyamoorthy K, Meier F, Gardiner BB, Smit DJ, Vaidya B and Herlyn M. (2002). Cancer Res., 62, 226-232.
55. Thomas R, True LD, Bassuk JA, Lange PH and Vessella RL. (2000). Clin. Cancer Res., 6, 1140-1149.
56. Tiniakos DG, Scott LE, Corbett IP, Piggott NH and Horne CH. (1994). J. Pathol., 172, 19-26.
57. Touray M, Ryan F, Jaggi R and Martin F. (1991). Oncogene, 6, 1227-1234.
58. Ubeda M, Vallejo M and Habener JF. (1999). Mol. Cell. Biol., 19, 7589-7599.
59. van Dam H and Castellazzi M. (2001). Oncogene, 20, 2453-2464.
60. Vial E and Castellazzi M. (2000). Oncogene, 19, 1772-1782.
61. Vial E, Perez S and Castellazzi M. (2000). Oncogene, 19, 5020-5029.
62. Vogt PK. (2001). Oncogene, 20, 2365-2377.
63. Yamanaka M, Kanda K, Li NC, Fukumori T, Oka N, Kanayama HO and Kagawa S. (2001). J. Urol., 166, 2495-2499.
64. Yan Q and Sage EH. (1999). J. Histochem. Cytochem., 47, 1495-1506.
65. Yang-Yen H-F, Chambard J-C, Sun Y-L, Smeal T, Schmidt TJ, Drouin J and Karin M. (1990). Cell, 62, 1205-1215.
66. Yang-Yen H-F, Zhang X-k, Graupner G, Tzukerman M, Sakamoto B, Karin M and Pfahl M. (1991). The New Biologist, 3, 1206-1219.
67. Yiu GK, Chan WY, Ng SW, Chan PS, Cheung KK, Berkowitz RS and Mok SC. (2001). Am. J. Pathol., 159, 609-622.
68. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP and Johnson PH. (2001). Cancer Res., 61, 5168-5178.